| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8286093 | Parkinsonism & Related Disorders | 2016 | 7 Pages |
Abstract
VPA is a potentially beneficial agent for the treatment of SCA3/MJD. These results also provide insight into possible future therapeutics for polyQ diseases.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Li-Fang Lei, Guo-Ping Yang, Jun-Ling Wang, De-Maw Chuang, Wei-Hong Song, Bei-Sha Tang, Hong Jiang,